Indicated for: invasive candidiasis; fungal infections
Route of administration: infusion
Substance: caspofungin (antifungal)
ATC: J02AX04 (Antiinfectives for systemic use | Antimycotics for systemic use | Other antimycotics for systemic use)
Caspofungin is an antifungal medication used for the treatment of invasive fungal infections, such as invasive candidiasis and aspergillosis. It belongs to the echinocandin class and works by inhibiting the synthesis of the fungal cell wall, leading to fungal destruction.
Caspofungin is administered intravenously and is particularly indicated for patients who cannot tolerate other antifungals or who do not respond to standard treatments. The dosage is adjusted based on the patient's weight and the severity of the infection.
Treatment requires close monitoring to assess the patient's response and detect potential side effects. It is important for patients to inform their doctor about any other medications they are taking to avoid interactions.
Side effects may include fever, nausea, headache, injection site reactions, or, in rare cases, severe allergic reactions. Patients should inform their doctor of any unusual symptoms.
G10 (C1) - Leukemias, lymphomas and bone marrow aplasia, tumors
Price
Copayment
Patient
1361.45 RON
1361.45 RON
0.00 RON
GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)
Price
Copayment
Patient
1361.45 RON
1361.45 RON
0.00 RON
NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment
Price
Copayment
Patient
1361.45 RON
1361.45 RON
0.00 RON
NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant
Price
Copayment
Patient
1361.45 RON
1361.45 RON
0.00 RON